Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06822179
What this trial is testing

Effectiveness of a Personalized In-home Telerehabilitation Program on Self-Care in Patients With Long COVID

Who this might be right for
Long COVID Syndrome
CEU San Pablo University 57
Not applicableLooking for participantsNCT04579588
What this trial is testing

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Who this might be right for
Corona Virus InfectionFlu VaccineImmunity
Stanford University 230
Testing effectiveness (Phase 2)UnknownNCT05200754
What this trial is testing

Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19

Who this might be right for
SARS-CoV-2 Infection
Carsten Müller-Tidow 174
Not applicableStudy completedNCT05753241
What this trial is testing

The Relationship Between Allergic Rhinitis and the Risk of Symptom in Patients With Mild COVID-19

Who this might be right for
COVID-19Allergic Rhinitis
qinxiu zhang 1,100
Not applicableUnknownNCT05670275
What this trial is testing

Microecology and Host Immunity in Patients With Severe COVID-19 Infection

Who this might be right for
Microbiome,Immune Function, Critically Ill
Chinese PLA General Hospital 200
Not applicableUnknownNCT05038475
What this trial is testing

Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionOlfactory Disorder+3 more
Association "Naso Sano" Onlus 100
Early research (Phase 1)Study completedNCT06063330
What this trial is testing

Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

Who this might be right for
COVID-19Infectious DiseaseSymptomatic COVID-19 Infection Laboratory-Confirmed+1 more
Red Queen Therapeutics, Inc. 66
Large-scale testing (Phase 3)Study completedNCT05897541
What this trial is testing

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

Who this might be right for
SARS-CoV-2 Infection
Shionogi 3,701
Not applicableUnknownNCT04964154
What this trial is testing

Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans' Perceptions/Beliefs About COVID-19 Testing and Vaccination Study

Who this might be right for
Covid19 Virus Infection
North Carolina Central University 4,000
Not applicableStudy completedNCT04481529
What this trial is testing

COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector

Who this might be right for
Infection Viral
University Hospital, Limoges 1,576
Not applicableUnknownNCT05520931
What this trial is testing

Pain-related Long Covid in Covid-19 Survivors

Who this might be right for
COVID-19Pain, Chronic
Aalborg University 600,000
Testing effectiveness (Phase 2)Ended earlyNCT04414631
What this trial is testing

Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Who this might be right for
Coronavirus Infections
University Hospital, Basel, Switzerland 80
Not applicableStudy completedNCT04750330
What this trial is testing

Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection

Who this might be right for
Covid19
Maastricht University 394
Large-scale testing (Phase 3)Study completedNCT06383819
What this trial is testing

Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

Who this might be right for
Post-Acute COVID-19 SyndromeLung Disease With PolymyositisFibrosis+2 more
NPO Petrovax 392
Not applicableStudy completedNCT06528145
What this trial is testing

Long Covid (Individuals with Ongoing COVID-19 Symptoms) Ongoing Effects

Who this might be right for
COVID-19 Infection
Ziya Yildiz 70
Early research (Phase 1)Study completedNCT05351437
What this trial is testing

To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.

Who this might be right for
SARS-CoV-2 Infection
Memo Therapeutics AG 32
Not applicableUnknownNCT06085911
What this trial is testing

RCT Long COVID-19 Rehabilitation

Who this might be right for
RehabilitationPost-Acute COVID-19 SyndromePost-Infectious Disorders
University Hospital of North Norway 60
Not applicableStudy completedNCT05356936
What this trial is testing

Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatology and Inflammatory Biomarkers

Who this might be right for
Post-acute COVID-19 Syndrome
University Hospitals Cleveland Medical Center 151
Not applicableUnknownNCT05803395
What this trial is testing

Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.

Who this might be right for
Chronic Lymphocytic LeukemiaIndolent B-Cell Non-Hodgkin LymphomaCOVID-19
Gruppo Italiano Malattie EMatologiche dell'Adulto 954
Not applicableStudy completedNCT05222139
What this trial is testing

Monitoring COVID-19 Vaccination Response in Fragile Populations

Who this might be right for
SARS CoV 2 InfectionVaccination; InfectionBreakthrough Infection
University of Bologna 8,894
Next Page